VR Logo

Novartis AG - ADR download report


Healthcare | Drugs & Pharma

Novartis AG - ADR Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

IPO Date: 18-Nov-1991

Chief Exec. Officer: Dr. Vasant Narasimhan

Chief Financial Officer: Mr. Harry Kirsch

Listing: NYSE: NVS

Country: Switzerland

Headquarters: Basel,

Website: https://www.novartis.com

Key Facts

Market cap: $189,144.61 Mln

Revenue (TTM): $52,997.00 Mln

Earnings (TTM): $24,184.00 Mln

Cash: $18,814.00 Mln

Total Debt: $0.00 Mln

Insider's Holding: 0.01%

Liquidity: Low

52 Week range: $76.15 - 94.26

Shares outstanding: 2,212,600,064

10 Years Aggregate:

  • CFO: $133,876.00 Mln
  • EBITDA: $197,747.00 Mln
  • Net Profit: $117,524.00 Mln

Stock Performance

Time Period Novartis AG - ADR S&P BSE Sensex* S&P BSE Healthcare*
YTD1.04-8.39-16.70
1 month-6.48-1.63-1.56
3 months-0.84-6.97-10.30
1 Year-4.340.83-13.03
3 Years0.9910.4619.26
5 Years5.9811.389.26
10 Years9.6112.1812.50
As on 24-Jun-2022 *As on 27-Jun-2022
Year Novartis AG - ADR S&P BSE Sensex S&P BSE Healthcare
2021-7.3721.9920.87
2020-0.2715.7561.45
201924.8114.38-3.55
20182.195.87-5.89
201715.2727.910.49
2016-15.341.95-12.88
2015-7.14-5.0315.06